GRCE
Grace Therapeutics
GRCE
GRCE
27 hedge funds and large institutions have $6.67M invested in Grace Therapeutics in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$662K | |
| 2 | +$647K | |
| 3 | +$475K | |
| 4 |
MFS
Monetta Financial Services
Wheaton,
Illinois
|
+$189K |
| 5 |
OC
Oppenheimer & Co
New York
|
+$104K |
Top Sellers
| 1 | -$380K | |
| 2 | -$69.8K | |
| 3 | -$65.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$16.9K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7K |